When should we measure lipoprotein (a)?

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

(2013) Paul Jellinger et al.   Endocrine Practice

FGF19 Signaling Cascade Suppresses APOA Gene Expression

(2012) Indumathi Chennamsetty et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lipoprotein(a)

(2012) Joseph B. Dubé et al.   CURRENT OPINION IN LIPIDOLOGY

Lipid-Related Markers and Cardiovascular Disease Prediction

(2012)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Nicotinic acid inhibits hepaticAPOAgene expression: studies in humans and in transgenic mice

(2012) Indumathi Chennamsetty et al.   JOURNAL OF LIPID RESEARCH

Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia

(2012) Eli M. Roth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease

(2011) Yonghong Li et al.   Circulation-Cardiovascular Genetics

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Farnesoid X receptor represses hepatic human APOA gene expression

(2011) Indumathi Chennamsetty et al.   JOURNAL OF CLINICAL INVESTIGATION

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

(2011) Heribert Schunkert et al.   NATURE GENETICS

A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease

(2011) John F Peden et al.   NATURE GENETICS

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans

(2011) Heiner K. Berthold et al.   PLoS One

Lipoprotein(a): From Molecules to Therapeutics

(2010) Valmore Bermúdez et al.   AMERICAN JOURNAL OF THERAPEUTICS

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

(2010) et al.   CIRCULATION

Lipoprotein(a) and Risk of Type 2 Diabetes

(2010) S. Mora et al.   CLINICAL CHEMISTRY

Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease

(2010) Kåre Berg et al.   CLINICAL GENETICS

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Apolipoprotein(a) Isoforms and the Risk of Vascular Disease

(2010) Sebhat Erqou et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

(2010) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

(2010) Olaf Schultz et al.   PLoS One

Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk

(2010) James Ronald et al.   STROKE

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

(2010) Karen L. Furie et al.   STROKE

Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis

(2009) Eric Bruckert et al.   ATHEROSCLEROSIS

Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians

(2009) Matthew B. Lanktree et al.   Circulation-Cardiovascular Genetics

Lipoprotein(a): a causal independent risk factor for coronary heart disease?

(2009) Vilmundur Gudnason   CURRENT OPINION IN CARDIOLOGY

Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction

(2009) Pia R. Kamstrup   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality

(2009)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease

(2009) David-Alexandre Trégouët et al.   NATURE GENETICS

Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events

(2009) Beate R Jaeger et al.   Nature Reviews Cardiology

Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

(2009) Robert Clarke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area

(2008) Jonathan H. Klein et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pentanucleotide Repeat Polymorphism, Lipoprotein(a) Levels, and Risk of Ischemic Heart Disease

(2008) Pia R. Kamstrup et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Analysis of 17,576 Potentially Functional SNPs in Three Case–Control Studies of Myocardial Infarction

(2008) Dov Shiffman et al.   PLoS One

Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study

(2007) Dov Shiffman et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY